| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/19/2008 | WO2008072799A1 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
| 06/19/2008 | WO2008072779A1 Quinoxaline derivative |
| 06/19/2008 | WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | WO2008072725A1 Composition containing agaricus blazei murill |
| 06/19/2008 | WO2008072724A1 Pyrazole derivative |
| 06/19/2008 | WO2008072703A1 Biphenylamide derivative |
| 06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
| 06/19/2008 | WO2008072658A1 2-phenylnicotinic acid derivative |
| 06/19/2008 | WO2008072591A1 Iron metabolism-improving agent |
| 06/19/2008 | WO2008072385A1 Therapeutic agent for disease caused by accumulation of body fat |
| 06/19/2008 | WO2008072360A1 Catechin composition and method for producing the same |
| 06/19/2008 | WO2008072061A1 Method of treatment of obesity with an mtp inhibitor in conjunction with an increased-fat diet |
| 06/19/2008 | WO2008072056A1 Use of mtp inhibitors for the treatment of obesity using low doses and dose-escalation |
| 06/19/2008 | WO2008071790A2 Novel compositions and uses thereof |
| 06/19/2008 | WO2008071667A1 Nutritional composition |
| 06/19/2008 | WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/19/2008 | WO2008071311A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/19/2008 | WO2008071079A1 Composition for reducing blood sugar, reducing blood fat, controlling diabetes complication |
| 06/19/2008 | WO2008071010A1 Combination treatments with selected growth/hormone regulatory factors for diabetes and related diseases |
| 06/19/2008 | WO2008070992A1 Trpv1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 06/19/2008 | WO2008070948A1 Extracts from the skin of fruits of plants from genus vitis, compositions containing the same and a process for its manufacture |
| 06/19/2008 | WO2008051794A3 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 06/19/2008 | WO2008051793A3 Method of preventing or treating metabolic syndrome |
| 06/19/2008 | WO2008049984A3 Use of citrulline for treating undernutrition conditions |
| 06/19/2008 | WO2008045566B1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/19/2008 | WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 06/19/2008 | WO2008035207A3 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 06/19/2008 | WO2008031439A3 Treatment of insulin resistance or diseases associated with insulin resistance with bicyclo [ 3.2. i ]octans such as steviol and isosteviol |
| 06/19/2008 | WO2008008507A3 Methods of treatment of diabetes |
| 06/19/2008 | WO2007121447A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 06/19/2008 | WO2007036730A9 Thiophene derivatives as ppar agonists i |
| 06/19/2008 | US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
| 06/19/2008 | US20080146817 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 06/19/2008 | US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/19/2008 | US20080146664 Method for treating diseases caused by accumulation of body fat |
| 06/19/2008 | US20080146659 Administering Taxiresinol, (7'R)-7'-Hydroxylariciresinol, Secoisolariciresinol and Isotaxiresinol, which are lignans contained in Hongdoushan contained in Hongdoushan, as the active ingredients for reducing the blood glucose level |
| 06/19/2008 | US20080146657 Plant-Origin Alpha3-Adrenoceptor Agonist and Use of the Same |
| 06/19/2008 | US20080146656 May be useful for treatment of hirsutism, excess sebum production, benign breast disease, benign ovarian disease, polycystic ovarian disease, female infertility; steroid sulphatase, aromatase inhibitors or modulators of apoptosis, cell cycling, cell growth; sulphamate group-containing coumarin compounds |
| 06/19/2008 | US20080146655 Pharmaceutical Composition for the Treatment or Prevention of Diseases Involving Obesity, Diabetes, Metabolic Syndrome, Neuro-Degenerative Diseases and Mitochondria Dyfunction Diseases |
| 06/19/2008 | US20080146646 For therapy of pain, inflammation, urological disorders, gynecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritation, herpes or zona, diabetes, depression |
| 06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
| 06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 06/19/2008 | US20080146636 For therapy of obesity, hyperphagia, anxiety, depression and related disorders and diseases; cis-(S)-2-(1-{4-[(5-Bromo-indan-2-ylmethyl)-amino]-cyclohexyl}-5-chloro-1H-benzoimidazol-2-yl)-propan-2-ol |
| 06/19/2008 | US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 06/19/2008 | US20080146630 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146625 Oxime glucokinase activators |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/19/2008 | US20080146578 Indolylmaleimide derivatives |
| 06/19/2008 | US20080146574 Heterocycle Substituted Carboxylic Acids |
| 06/19/2008 | US20080146547 e.g. 4-Chloro-1-hydroxy-phthalazine-6-carboxylic acid [4-chloro-3'-(2-dimethylamino-ethoxy)-biphenyl-3-yl]-amide; multifunctioning protein kinase inhibitors; anticarcinogenic, antiinflammatory, antidiabetic agent, neurodegenerative diseases |
| 06/19/2008 | US20080146543 Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 06/19/2008 | US20080146541 Methods for treating or preventing sysmptoms of hormonal variations |
| 06/19/2008 | US20080146532 Drug Screening and Treatment Methods |
| 06/19/2008 | US20080146531 Therapeutically Active Triazoles and Their Use |
| 06/19/2008 | US20080146520 Animal feeds containing polyols |
| 06/19/2008 | US20080146515 Canagliflozin, a sodium-glucose transporter 2 inhibitor as antiobesity, antidiabetic agent; purity; handling characteristics; easy formulation; storage stability |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146504 Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
| 06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 06/19/2008 | US20080146502 method for modulating the sensation of satiety perception and to agents useful for same. Such agents are useful in modulating, controlling or otherwise affecting inter alia obesity, anorexia, weight maintenance, metabolic energy levels and/or inflammatory conditions in a subject |
| 06/19/2008 | US20080146496 Novel Melanocortin Receptor Templates, Peptides, and Use Thereof |
| 06/19/2008 | US20080146490 Glp-1 Analogue Formulations |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145457 Administering saponins to an animal |
| 06/19/2008 | US20080145451 Composition for relieving discomfort |
| 06/19/2008 | US20080145433 Darusentan oral dosage form |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145354 Polyoxyethylene glycol; biocompatability; bioavailability |
| 06/19/2008 | US20080145348 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 06/19/2008 | DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma |
| 06/19/2008 | DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma |
| 06/19/2008 | DE10085149B4 Verfahren zur Herstellung von Acarbose mit hohem Reinheitsgrad A process for preparing acarbose with high purity |
| 06/19/2008 | CA2678524A1 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
| 06/19/2008 | CA2673054A1 Novel compositions and uses thereof |
| 06/19/2008 | CA2672585A1 Composition containing agaricus blazei murill |
| 06/19/2008 | CA2672490A1 Trpv1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 06/19/2008 | CA2672347A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/19/2008 | CA2672183A1 Extracts from the skin of fruits of plants from genus vitis, compositions containing the same and a process for its manufacture |
| 06/19/2008 | CA2672176A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | CA2672049A1 Monoclonal antibodies against angptl3 |
| 06/19/2008 | CA2671988A1 Nutritional composition |
| 06/19/2008 | CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/19/2008 | CA2671980A1 Quinoxaline derivatives |
| 06/19/2008 | CA2671040A1 Use of pkc inhibitors in transplantation |
| 06/18/2008 | EP1932843A1 Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/18/2008 | EP1932838A2 Beta-form crystal of acetanilide derivative |
| 06/18/2008 | EP1932543A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 06/18/2008 | EP1932542A1 Antioxidant composition and its use in diabetes |
| 06/18/2008 | EP1932535A2 Stimulation of beta cell profileration |
| 06/18/2008 | EP1932533A1 Composition for amelioration of body lipid |
| 06/18/2008 | EP1932532A1 Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation |
| 06/18/2008 | EP1932522A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 06/18/2008 | EP1932437A1 Infant formula |
| 06/18/2008 | EP1931666A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 06/18/2008 | EP1931665A1 1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist |
| 06/18/2008 | EP1931658A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 06/18/2008 | EP1931651A1 Thiophene derivatives for the treatment of diabetes |
| 06/18/2008 | EP1931633A2 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |